WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
WO2010084160A1
(en)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
WO2010143582A1
(ja)
|
2009-06-11 |
2010-12-16 |
公立大学法人名古屋市立大学 |
フェニルシクロプロピルアミン誘導体及びlsd1阻害剤
|
CA2812683C
(en)
|
2009-09-25 |
2017-10-10 |
Oryzon Genomics S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
EP2486002B1
(en)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
BR112012026694A2
(pt)
|
2010-04-19 |
2016-07-12 |
Oryzon Genomics Sa |
inibidores da desmetilase específica para lisina 1 e seu uso
|
EA022459B1
(ru)
|
2010-04-20 |
2016-01-29 |
Университа' Дельи Студи Ди Рома "Ла Сапиенца" |
Производные транилципромина в качестве ингибиторов гистон деметилаз lsd1 и/или lsd2
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
SI2598482T1
(sl)
|
2010-07-29 |
2018-09-28 |
Oryzon Genomics, S.A. |
Inhibitorji demetilaze lsd1 na osnovi arilciklopropilamina in njihova medicinska uporaba
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
SG193241A1
(en)
|
2011-03-25 |
2013-10-30 |
Glaxosmithkline Ip No 2 Ltd |
Cyclopropylamines as lsd1 inhibitors
|
KR20140052018A
(ko)
|
2011-08-09 |
2014-05-02 |
다케다 야쿠힌 고교 가부시키가이샤 |
시클로프로판아민 화합물
|
JP6122006B2
(ja)
|
2011-08-15 |
2017-04-26 |
ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション |
ヒストン脱メチル化酵素阻害剤としての、置換された(e)−n’−(1−フェニルエチリデン)ベンゾヒドラジド類似体
|
BR112014009238B1
(pt)
|
2011-10-20 |
2022-08-09 |
Oryzon Genomics S.A. |
Compostos de (hetero)aril ciclopropilamina, seus usos e composições farmacêuticas
|
JP6215212B2
(ja)
|
2011-10-20 |
2017-10-18 |
オリゾン・ジェノミックス・ソシエダッド・アノニマOryzon Genomics S.A. |
Lsd1阻害剤としての(ヘテロ)アリールシクロプロピルアミン化合物
|
US9751885B2
(en)
|
2012-10-12 |
2017-09-05 |
Takeda Pharmaceutical Company Limited |
Cyclopropanamine compound and use thereof
|
EP2927212A4
(en)
|
2012-11-28 |
2016-06-08 |
Univ Kyoto |
LSD1-SELECTIVE HEMMER WITH LYSINE STRUCTURE
|
EP2740474A1
(en)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
CN103054869A
(zh)
|
2013-01-18 |
2013-04-24 |
郑州大学 |
含三唑基的氨基二硫代甲酸酯化合物在制备以lsd1为靶标药物中的应用
|
WO2014164867A1
(en)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Kdm1a inhibitors for the treatment of disease
|
WO2014194280A2
(en)
|
2013-05-30 |
2014-12-04 |
The Board of Regents of the Nevada System of Higher Education on behalf of the University of |
Novel suicidal lsd1 inhibitors targeting sox2-expressing cancer cells
|
SG11201510376QA
(en)
|
2013-06-19 |
2016-01-28 |
Univ Utah Res Found |
Substituted (e)-n'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhibitors
|
CN103319466B
(zh)
|
2013-07-04 |
2016-03-16 |
郑州大学 |
含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用
|
NZ716427A
(en)
|
2013-08-06 |
2021-07-30 |
Imago Biosciences Inc |
Kdm1a inhibitors for the treatment of disease
|
US9556170B2
(en)
|
2013-08-30 |
2017-01-31 |
University Of Utah Research Foundation |
Substituted-1H-benzo[d]imidazole series compounds as lysine-specific demethylase 1 (LSD1) inhibitors
|
WO2015089192A1
(en)
|
2013-12-11 |
2015-06-18 |
Quanticel Pharmaceuticals, Inc. |
Inhibitors of lysine specific demethylase-1
|
EP3102034A4
(en)
|
2014-02-07 |
2017-07-12 |
MUSC Foundation For Research Development |
Aminotriazole- and aminotetrazole-based kdm1a inhibitors as epigenetic modulators
|
CN106488915B
(zh)
|
2014-02-13 |
2020-10-02 |
因赛特公司 |
作为lsd1抑制剂的环丙胺
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
EP3626713B1
(en)
|
2014-02-13 |
2021-09-29 |
Incyte Corporation |
Cyclopropylamines for use as lsd1 inhibitors
|
EP3392244A1
(en)
|
2014-02-13 |
2018-10-24 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
EP3114109A4
(en)
|
2014-03-07 |
2017-10-18 |
The Johns Hopkins University |
Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
|
EP3137169B1
(en)
|
2014-05-01 |
2021-11-10 |
Celgene Quanticel Research, Inc. |
Inhibitors of lysine specific demethylase-1
|
AU2015265820C1
(en)
|
2014-05-30 |
2020-01-16 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Cyclopropylamine compounds as histone demethylase inhibitors
|
WO2015200843A1
(en)
|
2014-06-27 |
2015-12-30 |
Quanticel Pharmaceuticals, Inc. |
Inhibitors of lysine specific demethylase-1
|
CN104119280B
(zh)
|
2014-06-27 |
2016-03-16 |
郑州大学 |
含氨基类脲与端炔结构单元的嘧啶衍生物、制备方法及应用
|
EP3164509B1
(en)
|
2014-07-03 |
2021-12-29 |
Celgene Quanticel Research, Inc. |
Inhibitors of lysine specific demethylase-1
|
EP3511319B1
(en)
|
2014-07-03 |
2023-05-03 |
Celgene Quanticel Research, Inc. |
Inhibitors of lysine specific demethylase-1
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
US9695168B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
US9695167B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
|
EP2993175A1
(en)
|
2014-09-05 |
2016-03-09 |
IEO - Istituto Europeo di Oncologia Srl |
Thienopyrroles as histone demethylase inhibitors
|
AU2015311805B2
(en)
|
2014-09-05 |
2020-04-02 |
Celgene Quanticel Research, Inc. |
Inhibitors of lysine specific demethylase-1
|
EP3250552B1
(en)
|
2015-01-30 |
2019-03-27 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
WO2016130952A1
(en)
|
2015-02-12 |
2016-08-18 |
Imago Biosciences, Inc. |
Kdm1a inhibitors for the treatment of disease
|
CN106146361A
(zh)
|
2015-03-16 |
2016-11-23 |
四川大学 |
茚-1-亚基磺酰基苯甲酰肼衍生物及其制备方法和用途
|
AU2016243939B2
(en)
|
2015-04-03 |
2020-09-03 |
Incyte Holdings Corporation |
Heterocyclic compounds as LSD1 inhibitors
|
CN106045862B
(zh)
|
2015-04-10 |
2019-04-23 |
上海迪诺医药科技有限公司 |
环丙胺类螺(杂)环化合物、其药物组合物及应用
|
EP3286172B1
(en)
|
2015-04-23 |
2019-06-12 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
EP3090998A1
(en)
|
2015-05-06 |
2016-11-09 |
F. Hoffmann-La Roche AG |
Solid forms
|
WO2017004519A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Utah Research Foundation |
Substituted benzohydrazide analogs as histone demethylase inhibitors
|
EA035534B1
(ru)
|
2015-08-12 |
2020-06-30 |
Инсайт Корпорейшн |
Соли ингибитора lsd1
|
WO2017079476A1
(en)
|
2015-11-05 |
2017-05-11 |
Mirati Therapeutics, Inc. |
Lsd1 inhibitors
|
CN108473442B
(zh)
|
2015-11-05 |
2022-03-25 |
赛尔基因昆蒂赛尔研究公司 |
包含赖氨酸特异性脱甲基酶-1的抑制剂的组合物
|
CA3006434C
(en)
|
2015-11-27 |
2021-03-16 |
Taiho Pharmaceutical Co., Ltd. |
Biphenyl compound or salt thereof
|
WO2017109061A1
(en)
|
2015-12-23 |
2017-06-29 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Spirocyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
CN105541806A
(zh)
|
2015-12-25 |
2016-05-04 |
中国药科大学 |
巴比妥酸类化合物、制备方法及其应用
|
CA3009805C
(en)
|
2015-12-29 |
2023-10-17 |
Mirati Therapeutics, Inc. |
Lsd1 inhibitors
|
CN105924362B
(zh)
|
2016-02-05 |
2018-08-17 |
上海龙翔生物医药开发有限公司 |
芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
|
US10590079B2
(en)
|
2016-03-01 |
2020-03-17 |
Novartis Ag |
Cyano-substituted indoles as LSD1 inhibitors
|
CN107176927B
(zh)
|
2016-03-12 |
2020-02-18 |
福建金乐医药科技有限公司 |
组蛋白去甲基化酶lsd1抑制剂
|
CN107174584B
(zh)
|
2016-03-12 |
2020-09-01 |
福建金乐医药科技有限公司 |
含哌嗪结构化合物在制备lsd1抑制剂中的应用
|
MY197785A
(en)
*
|
2016-03-15 |
2023-07-13 |
Oryzon Genomics Sa |
Combinations of lsd1 inhibitors for the treatment of hematological malignancies
|
CN107200706A
(zh)
|
2016-03-16 |
2017-09-26 |
中国科学院上海药物研究所 |
一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途
|
US20170283397A1
(en)
|
2016-03-31 |
2017-10-05 |
University Of Utah Research Foundation |
Substituted 1-h-indol-3-yl-benzamide and 1, 1'-biphenyl analogs as histone demethylase inhibitors
|
SG11201809299QA
(en)
|
2016-04-22 |
2018-11-29 |
Incyte Corp |
Formulations of an lsd1 inhibitor
|
AU2017263361B2
(en)
|
2016-05-09 |
2021-08-05 |
Jubilant Epicore LLC |
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors
|
EP3246330A1
(en)
|
2016-05-18 |
2017-11-22 |
Istituto Europeo di Oncologia S.r.l. |
Imidazoles as histone demethylase inhibitors
|
CN106045881B
(zh)
|
2016-05-26 |
2017-10-31 |
新乡医学院 |
一类白藜芦醇衍生物、其制备方法及作为lsd1抑制剂的应用
|
CN107459476B
(zh)
|
2016-06-03 |
2022-06-24 |
中国科学院上海药物研究所 |
反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途
|
CN107513068A
(zh)
|
2016-06-16 |
2017-12-26 |
中国科学院上海药物研究所 |
一种具有fgfr抑制活性的新型化合物及其制备和应用
|
US11390590B2
(en)
|
2016-08-16 |
2022-07-19 |
Imago Biosciences, Inc. |
Methods and processes for the preparation of KDM1A inhibitors
|
CN106478639B
(zh)
|
2016-09-05 |
2018-09-18 |
郑州大学 |
嘧啶并1,2,4–三氮唑类的lsd1抑制剂、其制备方法及应用
|
CN106432248B
(zh)
|
2016-09-27 |
2018-11-27 |
郑州大学 |
含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用
|
RS64889B1
(sr)
|
2016-10-26 |
2023-12-29 |
Constellation Pharmaceuticals Inc |
Inhibitori lsd1 i njihova medicinska upotreba
|
WO2018081342A1
(en)
|
2016-10-26 |
2018-05-03 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
CN110248926B
(zh)
|
2017-01-24 |
2022-12-06 |
石药集团中奇制药技术(石家庄)有限公司 |
Lsd1抑制剂及其制备方法和应用
|
CN108530302A
(zh)
|
2017-03-06 |
2018-09-14 |
华东师范大学 |
2`,3`-二氢螺[环丙烷-1,1`-茚]-2-胺衍生物及其制备方法和应用
|
CN106831489B
(zh)
|
2017-03-23 |
2018-04-17 |
郑州大学 |
苯环丙胺酰腙类化合物、制备方法及其应用
|
CN107033148B
(zh)
|
2017-05-03 |
2018-10-26 |
郑州大学 |
含嘧啶并三氮唑—巯基四氮唑类lsd1抑制剂、其制备方法及应用
|
CN106928235A
(zh)
|
2017-05-03 |
2017-07-07 |
郑州大学 |
含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用
|
WO2018213211A1
(en)
|
2017-05-15 |
2018-11-22 |
The Regents Of The University Of Michigan |
Pyrrolo[2,3-c]pyridines and related analogs as lsd-1 inhibitors
|
US11479563B2
(en)
|
2017-05-26 |
2022-10-25 |
Taiho Pharmaceutical Co., Ltd. |
Biphenyl compound or salt thereof
|
KR20180134675A
(ko)
|
2017-06-09 |
2018-12-19 |
한미약품 주식회사 |
시클로프로필아민 유도체 화합물 및 이의 용도
|
UY37774A
(es)
|
2017-06-19 |
2019-01-31 |
Novartis Ag |
Compuestos 5-cianoindol sustituidos y usos de los mismos
|
JP2020152641A
(ja)
|
2017-07-07 |
2020-09-24 |
国立研究開発法人理化学研究所 |
リジン特異的脱メチル化酵素1阻害活性を有する新規化合物、その製造方法及びその用途
|
EP3668877B1
(en)
|
2017-08-18 |
2024-05-01 |
Istituto Europeo di Oncologia S.r.l. |
Indole derivatives as histone demethylase inhibitors
|
CN107474011B
(zh)
|
2017-08-25 |
2020-03-27 |
新乡医学院 |
一类2-苯基-4-苯乙烯基吡啶类lsd1抑制剂、其制备方法及应用
|
CN107501169B
(zh)
|
2017-08-25 |
2020-03-27 |
新乡医学院 |
一类反式二芳基乙烯类lsd1抑制剂、其制备方法及应用
|
AR112900A1
(es)
|
2017-09-13 |
2019-12-26 |
Hanmi Pharm Ind Co Ltd |
Compuesto derivado de pirazol y uso de este
|
CN109535019B
(zh)
|
2017-09-21 |
2021-08-20 |
华东师范大学 |
1,1a,6,6a-四氢环丙并[a]茚-1-胺衍生物及其制备方法与应用
|
KR20190040763A
(ko)
|
2017-10-11 |
2019-04-19 |
한미약품 주식회사 |
피라졸로피리딘 유도체 화합물 및 이의 용도
|
KR20190040783A
(ko)
|
2017-10-11 |
2019-04-19 |
한미약품 주식회사 |
라이신 특이적 데메틸라제-1 억제제로서의 피라졸 유도체
|
CN107936022A
(zh)
|
2017-11-30 |
2018-04-20 |
郑州大学 |
黄嘌呤类lsd1抑制剂及其制备方法和应用
|
CN110204551B
(zh)
|
2018-02-28 |
2021-08-17 |
中国科学院上海药物研究所 |
一类含环丙胺结构的噻吩并[3,2-d]嘧啶衍生物、其制备方法与用途
|
KR20210006426A
(ko)
|
2018-05-04 |
2021-01-18 |
오리존 지노믹스 에스.에이. |
안정한 약제학적 제제
|
JP7450559B2
(ja)
|
2018-05-11 |
2024-03-15 |
イマーゴ バイオサイエンシーズ インコーポレイテッド |
疾患の処置のためのkdm1a阻害剤
|
US11944614B2
(en)
|
2018-05-15 |
2024-04-02 |
Regents Of The University Of Michigan |
Imidazo[4,5-c]pyridine compounds as LSD-1 inhibitors
|
CN112424175B
(zh)
|
2018-07-20 |
2022-10-28 |
石药集团中奇制药技术(石家庄)有限公司 |
一种lsd1抑制剂的盐及其晶型
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|
CN112672994B
(zh)
|
2018-09-13 |
2022-09-13 |
南昌弘益药业有限公司 |
作为lsd1抑制剂的杂螺环类化合物及其应用
|
WO2020052649A1
(zh)
|
2018-09-13 |
2020-03-19 |
南京明德新药研发有限公司 |
作为lsd1抑制剂的环丙胺类化合物及其应用
|
CN109265462B
(zh)
|
2018-10-31 |
2020-06-02 |
郑州大学 |
嘧啶并1,2,4-三氮唑类化合物及其制备方法和应用
|
CN109293664B
(zh)
|
2018-11-14 |
2020-06-02 |
郑州大学 |
嘧啶并1,2,4-三氮唑肼类化合物及其制备方法和应用
|
JPWO2020138398A1
(ja)
|
2018-12-28 |
2021-11-04 |
国立研究開発法人理化学研究所 |
リジン特異的脱メチル化酵素1を阻害する新規化合物、その製造方法及びその用途
|
WO2020159285A1
(ko)
|
2019-02-01 |
2020-08-06 |
한미약품 주식회사 |
이미다조피리딘 유도체 화합물 및 이의 용도
|
CA3127993A1
(en)
|
2019-02-01 |
2020-08-06 |
Hanmi Pharm. Co., Ltd. |
Imidazopyridine derivative compounds and use of same
|
CN112110936B
(zh)
|
2019-06-20 |
2021-12-07 |
沈阳药科大学 |
四氢喹啉类衍生物及其制备方法和应用
|
CN110478352A
(zh)
|
2019-08-30 |
2019-11-22 |
郑州大学 |
含三唑基的5-氰基-6-苯基-嘧啶类化合物在抑制lsd1中的应用及lsd1抑制剂
|
WO2021058024A1
(zh)
|
2019-09-29 |
2021-04-01 |
南京明德新药研发有限公司 |
Lsd1抑制剂
|
EP4058018A4
(en)
|
2019-11-13 |
2023-06-21 |
Taiho Pharmaceutical Co., Ltd. |
METHODS OF TREATMENT OF LSD1-RELATED DISEASES AND DISORDERS USING LSD1 INHIBITORS
|
CN111072610B
(zh)
|
2019-12-16 |
2022-08-30 |
杭州师范大学 |
一类取代的苯并呋喃2-甲酰腙类lsd1抑制剂的制备和应用
|
CN113354622B
(zh)
|
2020-03-06 |
2022-11-01 |
沈阳药科大学 |
对苯二胺类lsd1抑制剂及其制备方法
|
CN111454252B
(zh)
|
2020-05-13 |
2021-06-11 |
郑州大学 |
含芳环/芳杂环-三氮唑-亚甲基-tcp衍生物及其制备方法和应用
|
CN114105950B
(zh)
|
2020-08-31 |
2022-09-06 |
南京明德新药研发有限公司 |
吡唑类化合物及其应用
|
CN112409310B
(zh)
|
2020-12-18 |
2023-04-21 |
许昌学院 |
一种具有lsd1抑制活性的化合物、制备方法及应用
|
CN113087712B
(zh)
|
2021-04-12 |
2022-02-22 |
郑州大学 |
L-氨基酸-6-胶霉毒素酯三氟乙酸盐及其制备方法
|
CN113105479B
(zh)
|
2021-04-12 |
2022-07-01 |
郑州大学 |
胶霉毒素6-芳香环羧酸酯系列衍生物及其制备方法
|
CN113264903A
(zh)
|
2021-05-27 |
2021-08-17 |
郑州大学 |
一种吩噻嗪类化合物及其制备方法和应用
|
CN113599380A
(zh)
|
2021-08-24 |
2021-11-05 |
郑州大学 |
小檗碱类化合物在制备抗肿瘤药物中的应用
|
CN113582906B
(zh)
|
2021-08-24 |
2023-05-16 |
郑州大学 |
二氟苯环丙胺类化合物及其制备方法和应用
|